Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

30.25
Delayed Data
As of Aug 29
 -0.58 / -1.88%
Today’s Change
18.55
Today|||52-Week Range
245.82
-70.24%
Year-to-Date
Valeant (VRX) Stock Falls on Lawsuit
Aug 29 / TheStreet.com - Paid Partner Content
Forget Mylan, Buy These 3 Drug Stocks Instead
Aug 26 / Zacks.com - Paid Partner Content
Healthcare Winners: Stryker Corp., UnitedHealth Group Inc.
Aug 29 / GuruFocus News - Paid Partner Content
Today's Good, Bad and Ugly
Aug 25 / TheStreet.com - Paid Partner Content
Bill Ackman Comments on Valeant
Aug 29 / GuruFocus News - Paid Partner Content
Here's A Reason Why Valeant (VRX) Stock Is Climbing Today
Aug 25 / TheStreet.com - Paid Partner Content
Pharma Has History of Price Gouging, Mylan Should Be No Surprise
Aug 26 / TheStreet.com - Paid Partner Content
Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny
Aug 25 / TheStreet.com - Paid Partner Content
Bill Ackman: Valeant 'One Very Big Mistake'
Aug 26 / GuruFocus News - Paid Partner Content
EpiPen CEO: Blame the 'broken' system, not me
Aug 25 / CNNMoney.com

Today’s Trading

Previous close30.83
Today’s open30.85
Day’s range29.98 - 31.20
Volume19,088,304
Average volume (3 months)31,003,304
Market cap$10.5B
Dividend yield--
Data as of 08/29/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-35.41%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book1.79

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+0.43+0.49%
MNKMallinckrodt Plc-0.72-0.96%
JAZZJazz Pharmaceuticals...-1.79-1.39%
RDYDr.Reddy's Laborator...+0.10+0.22%
Data as of 08/29/2016

Financials

Next reporting dateOctober 17, 2016
EPS forecast (this quarter)$1.80
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts

Partner Offers

Search for Jobs